A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Pas encore traduit Pas encore traduit
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Loading references information
The endpoint is to investigate if the addition of low molecular heparin - enoxaparin, will result in a significant increase of overall survival in patients with small cell lung cancer, receiving standard chemotherapy.
Epistemonikos ID: e7a21e71941649e8182885ce9a7d15aaa0ae7631
First added on: Feb 23, 2021